- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2019-001358-24. Displaying page 1 of 1.
|EudraCT Number: 2019-001358-24||Sponsor Protocol Number: B9991040||Start Date*: Information not available in EudraCT|
|Sponsor Name:Pfizer Inc.|
|Full Title: A Phase 1b/2 Study to Evaluate Safety and Clinical Activity of Avelumab in Combination with Bempegaldesleukin (NKTR-214) with or without Talazoparib or Enzalutamide in Participants with Locally Adv...|
|Medical condition: Locally recurrent (not amenable for curative intent) or metastatic squamous cell carcinoma of the of the oral cavity, oropharynx, hypopharynx, or larynx; metastatic castration-resistant prostate...|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: PL (Completed) IT (Prematurely Ended) ES (Prematurely Ended) BE (Completed)|
|Trial results: (No results available)|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.